Ten Years of Extracellular Matrix Proteomics: Accomplishments, Challenges, and Future Perspectives
Molecular & Cellular Proteomics · 2023-04 · 22 (4) · 100528
DOI: 10.1016/j.mcpro.2023.100528 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular & Cellular Proteomics, 2023-04. Verfasst von Alexandra Naba. Beteiligte Einrichtung: Department of Physiology and Biophysics, University of Illinois at Chicago, Chicago, Illinois, USA; University of Illinois Cancer Center, Chicago, Il…. Hauptthemen laut MEDLINE: Proteomics, Neoplasms. Die Arbeit wurde bisher 120-mal zitiert (Crossref) und nennt 207 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NHGRI NIH HHS, National Human Genome Research Institute.
Abstract (Originalsprache)
The extracellular matrix (ECM) is a complex assembly of hundreds of proteins forming the architectural scaffold of multicellular organisms. In addition to its structural role, the ECM conveys signals orchestrating cellular phenotypes. Alterations of ECM composition, abundance, structure, or mechanics have been linked to diseases and disorders affecting all physiological systems, including fibrosis and cancer. Deciphering the protein composition of the ECM and how it changes in pathophysiological contexts is thus the first step toward understanding the roles of the ECM in health and disease and toward the development of therapeutic strategies to correct disease-causing ECM alterations. Potentially, the ECM also represents a vast, yet untapped reservoir of disease biomarkers. ECM proteins are characterized by unique biochemical properties that have hindered their study: they are large, heavily and uniquely posttranslationally modified, and highly insoluble. Overcoming these challenges, we and others have devised mass-spectrometry-based proteomic approaches to define the ECM composition, or "matrisome," of tissues. This first part of this review provides a historical overview of ECM proteomics research and presents the latest advances that now allow the profiling of the ECM of healthy and diseased tissues. The second part highlights recent examples illustrating how ECM proteomics has emerged as a powerful discovery pipeline to identify prognostic cancer biomarkers. The third part discusses remaining challenges limiting our ability to translate findings to clinical application and proposes approaches to overcome them. Lastly, the review introduces readers to resources available to facilitate the interpretation of ECM proteomics datasets. The ECM was once thought to be impenetrable. Mass spectrometry-based proteomics has proven to be a powerful tool to decode the ECM. In light of the progress made over the past decade, there are reasons to believe that the in-depth exploration of the matrisome is within reach and that we may soon witness the first translational application of ECM proteomics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Biophysics, University of Illinois at Chicago, Chicago, Illinois, USA; University of Illinois Cancer Center, Chicago, Illinois, USA. Electronic address: anaba@uic.edu.
Förderung
- NCI NIH HHS
- NHGRI NIH HHS
- National Human Genome Research Institute
- National Cancer Institute
Zitieren
APA
Naba, A. (2023). Ten Years of Extracellular Matrix Proteomics: Accomplishments, Challenges, and Future Perspectives. Molecular & Cellular Proteomics, 22(4), 100528. https://doi.org/10.1016/j.mcpro.2023.100528
Vancouver
Naba A. Ten Years of Extracellular Matrix Proteomics: Accomplishments, Challenges, and Future Perspectives. Molecular & Cellular Proteomics. 2023;22(4):100528. doi:10.1016/j.mcpro.2023.100528
BibTeX
@article{Naba2023,
author = {Naba, Alexandra},
title = {Ten Years of Extracellular Matrix Proteomics: Accomplishments, Challenges, and Future Perspectives},
journal = {Molecular & Cellular Proteomics},
year = {2023},
volume = {22},
number = {4},
pages = {100528},
doi = {10.1016/j.mcpro.2023.100528}
}
EUVIMED